The FDA has updated Ozempics labeling to include warnings about intestinal blockages, a serious gastrointestinal condition called ileus
Monique Sensenbrenner at a French lab and Gertrude Lindler at a German lab both demonstrated this effect in cell cultures, providing cross-laboratory validation of the nerve growth-promoting properties
Ambulatory blood pressure has been reduced with tirzepatide, which was partially, but not completely, related to weight changes [31], as have serum lipids, with reductions in LDL and non-HDL cholesterol after 72 weeks of tirzepatide [11]
Consistency is especially important when studying peptides, as even minor variations can alter outcome data or affect reproducibility
However, its crucial to remember that semaglutide is not intended for long-term use and should not be seen as a permanent weight management solution
The point here is simply that this is a real medication with real tradeoffs, prescribed and monitored by a clinician, not a casual add-on
